UCSF Helen Diller Family Comprehensive Cancer Center - People

About Us

News & Events

Medical Care

Support Services

People

Health Care Professionals

Researchers & Staff

Media Professionals

JOHN K. CHAN, M.D.

John A. Kerner Distinguished Professorship in Gynecologic Oncology, UCSF
Assistant Professor, Obstetrics, Gynecology, & Reproductive Sciences, UCSF; Director of Gynecologic Oncology, UCSF Helen Diller Family Comprehensive Cancer Center

CONTACT

(415) 353-9600 (appts)
(415) 353-7766 (fax)

Box 1702, UCSF; San Francisco, CA 94143-1702

additional websites:

UCSF Physician Referral Directory

EDUCATION
University of California, Berkeley, BA, 1987-91, Molecular Cell Biology University of California, Los Angeles, MD, 1991-95, Medicine
PROFESSIONAL EXPERIENCE
1999 - 2003	Clinical Instructor, Department of Obstetrics and Gynecology, University of California, Irvine UC Irvine Medical Center
2003 - 2007	Assistant Professor, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine
2007 - present	Assistant Professor, Director of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, San Francisco
2007 - present	Director of Division of Gynecologic Oncology, University of California, San Francisco, CA
2007 - present	John A. Kerner Distinguished Professorship in Gynecologic Oncology
HONORS & AWARDS
1995	School of Medicine's "Highest Honor for Compassion and Academic Excellence," UCLA School of Medicine
1999	National Cancer Institute / Gynecologic Cancer Foundation Research Fellowship (Honorary recipient)
1999	Resident Teacher of the Year, UC Irvine School of Medicine
2000	Clinical Research Fellowship Award, American Cancer Society
2002	Reproductive Scientist Development Award, National Institute of Health
2004	Outstanding Faculty Award, Dept. of Ob/Gyn, Stanford University
2005	Reproductive Scientist Development Award, (phase II) National Institute of Health
2005	Frank Lynch Essay Award, Pacific Coast Ob/Gyn Society
2005	Ted Adams poster award, Pacific Coast Ob/Gyn Society
2006	Investigator Award - Ovarian Cancer Immunotherapy - Stanford Cancer Center
2006	Investigator Award - Ovarian Cancer Population-based Program - Stanford Cancer Center
2006	Gynecologic Cancer Foundation (GCF) Research Award
SELECTED PUBLICATIONS
Chan, J.K., Monk, B., Cuccia, D., Pham, H., Rose, G.S., Gu, M., Berman, M.L., DiSaia, P.J., Berns, M., Tromberg, B., Tadir, Y. Fluorescence Laparoscopic Detection of Metastatic Ovarian Cancer Using 5-Aminolevulinic Acid in an Animal Model. Gynecol Oncol. 2002; 87(2):64-72.
Chan, J.K., Loizzi, V, Lin, Y, Osann, K., Brewster, W., DiSaia, P. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important? Obstet Gynecol. 2003; 102(1):156-61.
Chan, J.K., Loizzi, V., Magistris, A., Lin, F., Rutgers, J., Osann K., DiSaia P.J., Berman, M.L. The Significance of Molecular Markers in the Survival of Younger Women with Advanced Ovarian Cancer, Clin Cancer Res. 2004; 10(24):8538-43.
Chan, J.K., Zhang, M., Kaleb V., Loizzi, V., Benjamin J., Vasilev S., Osann, K., DiSaia, P.J. Prognostic Factors Responsible for Survival in Sex Cord Stromal Tumors of the Ovary - A Multivariate Analysis. Gynecol Oncol. 2005; 96:204-209.
Zhang, M.M., Cheung, M.K., Osann, K., Manuel, M.R., Gomez, S.L., Chan, J.K. Incidence, treatment patterns and outcomes of Asian women with uterine cancer: a population-based analysis. Obstet Gynecol. 2005;105(4):117S.
Chan, J.K., Manuel, M.R., Osann, K., Cheung, M.K. Progress and trends in ovarian cancer survival over the last 15 years. Gynecol Oncol. 2005; 96(3):910-911.
Cheung, M.K., Manuel, M.R., Osann, K., Husain, A., Chan, J.K. Progress in ovarian cancer survival over the last 15 years. Annual Meeting of the American College of Obstetrics & Gynecology, San Francisco, CA, 2005.
Chan, J.K., Pham, H., You XJ, Cloven NG, Burger RA, Rose GS, Van Nostrand K, Korc M, Disaia PJ, Fan H. Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model. Cancer Res. 2005;65: (8):3243-8.
Urban, R., Cheung, M.K., Osann, K., Leiserowitz, G.S., Chan, J.K. Ovarian carcinoma in younger versus older women: analysis of a SEER database. Western Association of Gynecologic Oncologists Meeting. Gynecol Oncol. 2005.
Chan, J.K., Magistris, A., Loizzi, V., Lin, F., Rutgers, J., Osann K., DiSaia P.J., Berman, M.L., Samoszuk, M., Mast cell density, angiogenesis, blood clotting and prognosis in women with advanced ovarian cancer, Gynecol Oncol. 2005;99(1):20-5.
Chan, J.K., Lin, S., McMeekin S., Berman, ML, Tumor Lysis Syndrome in Ovarian Cancer, Journal of Clinical Oncol. 2005;23(27):6794-5.
Samoszuk M., Kanakubo E., Chan, J.K. Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts, BMC Cancer. 2005; 5:121.
Chan, J.K., Hamilton, C.A., Cheung, M.K., Karami, M., Baker, J., Gall, J.M., Schulz, S., Thorne, S.H., Contag, C.H., Lum, G.L. Negrin, R.S., Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study. Clin Cancer Res. 2006;12(6):1859-67.
Chan, J.K., Manuel, M.R., Ciarvino, G., Husain, A., Teng, N.N., Safety and Efficacy of Thalidomide in Recurrent Epithelial Ovarian and Peritoneal Carcinoma. Gynecol Oncol. 2006; 103(3):919-23.
Chan, J.K., Manuel, M.R., Osann, K., Cheung, M.K. Progress and trends in ovarian cancer survival over the last 14 years. Obstet Gynecol. 2006; 108:521-8.
Chan, J.K., Cheung, M.K., Huh, W., Kapp, D.S., Osann, K. Extent of lymphadenectomy in surgically-staged endometrial carcinoma - is there a therapeutic benefit? Cancer. 2006; 107(8):1823-30.
Chan, J.K., Munro, E.G., Cheung, M.K., Husain, A., Teng, N.N., Berek, J.S., Osann, K., Lymphadenectomy improves the survival of women with stage I epithelial ovarian cancer. Obstet Gynecol. 2007;109(1):12-9.
Parthasarathy, A., Cheung, M.K., Osann, K., Kapp, D.S., Chan, J.K. The benefit of radiotherapy in single node-positive vulvar carcinoma, Gynecol Oncol. 2006;103(3):1095-1099.
Chan, J.K., Pham, H., Sugiyama, V., Gu, M., Rutgers, J., Osann, K., Berman M.L., DiSaia P.J. A Multivariate Analysis on Prognostic Factors in Vulvar Carcinoma: The Importance of Margin Distance and Other Pathologic Variables. Gynecol Oncol. 2006.
Chan, J.K., Urban, R., Cheung, M.K., Osann, K., Husain, A., Teng, N.N., Leiserowitz, G.S., Epithelial ovarian carcinoma in younger versus older women: a population-based analysis. Br J Cancer. 2006; 20; 95(10):1314-20.
Zhang, M., Chan, J.K., Husain, A., Guo, H.Y., Teng, N.N. Safety and Efficacy of Lenalidomide in Recurrent Ovarian and Primary Peritoneal Carcinoma. Gynecol Oncol. 2007; 105(1):194-8.
Zhang, M., Cheung, M.K., Hawaldar, P., Osann, K., Husain, A., Teng, N.N., Chan, J.K. Survival of women with sex cord stromal tumors of the ovary - A study of 376 women. Gynecol Oncol. 2007;104(2):396-400.
Chan, J.K., Hamilton, CA, Anderson, E.M., Karami, M., Baker, J., Husain, A., Teng, N.N., Negrin, R.S., A Novel Technique for the purification of ovarian cancer cells. Am J Obstet Gynecol. 2007;197(5):507.e1-5.
Lee, Karnik N., Cheung, M.K., Shin, J., Teng, N.N., Berek, J.S., Kapp, D.S., Osann, K., Chan, J.K. Uterine cancer in reproductive age women - What prognostic factors are important? Obstet Gynecol. in press.
Chan, J.K., Urban, R., Cheung, M.K., Osann, K., Husain, A., Teng, N.N., Kapp, D.S., Berek, J.S., Surgical staging for endometrioid uterine cancer - how many nodes are needed? Cancer. 2007;15;109(12):2454-60.
Chan, J.K., Urban, R., Hu, J.M., Shin, J.Y., Husain, A., Teng, N.N., Berek, J.S., Osann, K., Kapp, D.S. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Br J Cancer. 2007;96(12):1817-22.
Chan. J.K., Berek, J.S. The impact of the human papilloma vaccine on cervical cancer. J Clin Oncol. 2007; 25(20):2975-82.
Chan, J.K., Sugiyam,a V., Pham, H., Gu M., Rutgers, J., Osann, K. Cheung, M.K., Berman, M.L., Disaia, P.J. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol. 2007;104(3):636-41.
Chan, J.K., Kapp, D.S., Shin, J.Y., Husain, A., Teng, N.N., Berek, J.S., Osann, K., Leiserowitz, G.S., O' Malley, C. Access to gynecologic oncologists and its impact on survival of women with epithelial ovarian cancer. Obstet Gynecol. 2007; 109(6):1342-50.
Sugiyama, V.E., Chan, J.K., Shin, J.Y., Husain, A., Nelson N. Teng, Jonathan S. Berek, Kathryn Osann, Daniel S. Kapp, A multivariate analysis of vulvar melanomas - a study of 359 patients. Gyn Oncol. 2007 Aug;110(2 Pt 1):296-301.
Chan, J.K., Kapp, D.S. The role of complete lymphadenectomy in endometrioid uterine cancer. Lancet Oncol. 2007; 8(9):831-41.
Chan, J.K., Teng, N.N., Cheung, M.K., Husain, A., Osann, K., Berek, J.S., The significance of the ratio of metastatic to examined lymph nodes in endometrioid uterine cancer. Br J Cancer. 2007; 3;97(5):605-11.
Chan, J.K., Lee, N.K., Cheung, M.K., Osann, K., Husain, A., Teng, N.N., Kapp, D.S., Berek, J.S., The role of surgical staging in grade 1 endometrioid corpus cancer. Am J Obstet Gynecol., in press.
Chan, J.K., Lee, N.K., Wu, H.H., Cheung, M.K., Osann, K., Teng, N.N., Kapp, D.S. The impact of lymphadenectomy in women with endometrioid uterine cancer - a study of 39,396 women. Am J Obstet Gynecol. 2007;106(2):282-8.
Ueda, S.M., Kapp, D.S., Cheung, M.K., Shin, J.Y., Osann, K., Husain, A., Teng, N.N., Berek, J.S., Chan, J.K. Factors responsible for the increase in death rate of women diagnosed with uterine corpus cancer. Am J Obstet Gynecol. 2008;108(1):95-9.
Chan J.K., Urban, R., Cheung, M.K., Shin, J.Y., Husain, A., Teng, N.N., Berek, J.S., Walker, J.L., Kapp, D.S., Osann, K. Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients. Cancer. 200715; 109(12):2454-60.
Chan, J.K., Kapp, D.S., Cheung, M.K., Osann, K., Shin, J.Y., Cohn, D., Seid, P.L. The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients. Br J Cancer. 2007; 3;97(5):605-11.
1/28/08

This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device. Please upgrade your browser.